Return to Home 5-Year Rate Changes > Data Table

Data Table for 5-Year Rate Changes

5-Year Rate Changes - Incidence
Nevada, 2013-2017
Ages <50, Both Sexes, All Races (incl Hisp)

Cancer SiteEstimated Annual Percent Change
All Cancer Sites2.6# (1.4, 3.9)
Prostate (Male)-11.7# (-19.7, -2.9)
Lung & Bronchus-5.7# (-6.9, -4.4)
Liver & Bile Duct-3.3# (-5.8, -0.8)
Non-Hodgkin Lymphoma-2.3# (-3.7, -0.9)
Stomach-0.7 (-2.8, 1.5)
Oral Cavity & Pharynx-0.3 (-1.8, 1.1)
Breast (in situ) (Female)-0.2 (-1.5, 1.2)
Ovary (Female)-0.2 (-2.1, 1.8)
Breast (Female)0.5 (-0.3, 1.2)
Colon & Rectum1.2# (0.1, 2.3)
Leukemia1.9# (0.4, 3.5)
Thyroid2.4# (0.8, 4.1)
Uterus (Corp/Uterus NOS) (Fem)2.4# (0.8, 4.1)
Kidney & Renal Pelvis3.8# (2.0, 5.6)
Cervix (Female)9.0# (2.2, 16.2)
Melanoma of the Skin10.0 (-4.2, 26.3)
Brain & ONS*

Created by on 07/26/2021 7:46 pm.
Source: Incidence data provided by the National Program of Cancer Registries (NPCR). SEER*Stat Database (2001-2017) - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2019 submission).

AAPCs are calculated by the Joinpoint Regression Program and are based on APCs. Data are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84,85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ or unless otherwise specified. Population counts for denominators are based on Census populations as modifed by NCI. The 1969-2017 US Population Data File is used with SEER November 2017 data. Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html. Please note that the data comes from different sources. Due to different years of data availablility, most of the trends are AAPCs based on APCs but some are EAPCs calculated in SEER*Stat. Please refer to the source for each graph for additional information.

* - Unable to calculate annual percent change
# - The annual percent change is significantly different from zero (p<0.05).